We would love to hear your thoughts about our site and services, please take our survey here.
How do you know about the civil engineering works being underway? Very positive news if that is the case.
Just for clarity, my post was supposed to be full of sarcasm.
It�s not odd. The market has every faith that Ironveld will succeed. I reckon it will only take another decade to raise the finance.
it's taken approximately 1,009,491 days to build Rome - from a quick google search
How long to an income stream and how big an income stream. The usual Opti question after all of their announcements. Lets see what Mr. O�Hara had to say in his interview later...........
Why do you think I got 1:1 warrants? From memory warrants were only issued to subscribers who invested above a certain value before the consolidation or directors and folks associated the listing. From the admissions document As at the date of this document, the Company has a total of 913,592,460 Warrants in issue over Existing Ordinary Shares, further details of which are set out in paragraphs 14.7.1 and 14.7.2 of this Part VIII. Following the Share Consolidation, these will equate to 4,567,949 New Ordinary Shares subject to Warrants. On Admission, the Company has agreed to issue Warrants to subscribe for 538,159 New Ordinary Shares exercisable at the Issue Price to Cairn, further details of which are set out in paragraph 14.7.3 of this Part VIII. Probably best speaking to the company direct if you believe you are entitled.
Sadly not Opti. But interesting that ckingredients is a Canadian company and Per has just been to Canada. Clutching a straws, but maybe a connection of some sort.
�the SP also bounces back stronger�? Are you looking at the chart through special glasses?
I shall be buying on Monday. Friday, in my humble opinion, was the low point of the year.
16.45 Session 3: Scientific Frontiers Chaired by: Will Chu, Scientific Editor, NutraIngredients The authors of our highest rated Scientific Frontiers abstracts � selected by our Scientific Committee � present key findings and impacts of their research. Dr Sofia Kolida, OptiBiotix Health An in-vitro evaluation of different carbohydrates on the selective fermentation of Lactobacillus rhamnosus ATCC 53103
Tom, your thoughts on this latest dilution by warrants please. Oh, and where are the big news you have expected for nigh on two years? Maybe after this week�s conference in Spain? in greater scheme of things not massive. Those of us who backed the original placing at 8p got a 1 for 1 warrant at 8p. As far as I know it is just me and 1 other now left with warrants and we will exercise at some point soon, everyone else has now exercised. The reason is that we need to do so to get shares in Skinbio when they are distributed as an in specie div. So I am planning on exercising in next few months. In terms of news. Watch this space :). Am very relaxed
Im sure SoH will have arranged for an II to get these shares, he is often referring to II interest. Sadly not enough interest to actually buy in the market for such an exciting company with the prospects it has. I did write the first sentence just as a pig flew past my window.
A quarter of a ton of Slimbiome as a trial does sound promising, especially if followed quickly with a further half ton. I do hope that February starts the substantive news flow. Like you say, multiple opportunities,just need to start nailing them. Off topic, iqe does not look good for Monday.
Ok, not previously. Do you reckon we might here news this week, or will we have to wait until after Probiota?
I see you stole my find without accreditation on the other thread...,,,,
By /luis-gosalbez Achieving true selectivity in an ecosystem as complex as the human gut is difficult, which is evident in the common occurrence of gastrointestinal side effects upon prebiotic ingestion, and the reason why prebiotic precision is key in ensuring only targeted microbes are enhanced. LPGOS� from OptiBiotix is an example of selective microbiome focus�a galactooligosaccharide (GOS) specifically targeting L. plantarum LPLDL with the capacity to enhance its metabolic activity and growth within the gut microbiome. http://www.vitafoodsinsights.com/blogs/market-leaders/2018/01/the-microbiome-the-next-frontier-in-human-health.aspx
Possibly and hopefully you are right Elrico. My more pessimistic view was that CII are not up to manufacturing capacity just yet.
Primal, lots of investors do lots of research and have as much confidence in other companies as you do in Opti. Still, not all companies do succeed, often for factors outside of their control. So just because some investors sell, it does not make them fickle. I like you, have not sold any though.
Question: why ship a quarter of a ton of Slimbiome to the USA, when last year a deal was signed for Cereal Ingredients to manufacture it in the USA? Regardless, things seem a little more positive. Why it takes a drop into he 50�s for the company to go on the PR offensive I don�t know. All seems very reactive rather than proactive.
Struggling even for niche let alone mainstream